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Use of the Weibull distribution for
analysis of a clinical therapeutic study
in rheumatoid arthritis
W. R. McCrum, PhD *, J. T. Sharp, M D * * , and G. B. Bluhm, M D

This paper introduces
the use of the
Weibull distribution function for the analysis
of small samples of clinical data. It is compared with the use ofthe conventional analysis of variance in determining the results of
a study comparing the use of gold salts and a
placebo in the treatment of
rheumatoid
arthrids.
Although the samples were small, 14 control patients and 13 who were treated, analysis of variance determined several significant
differences between the two groups. The use
of the Weibull distribution, however, not
only confirmed these differences, but also
determined several more differences between the two groups that were undetected
by analysis of variance.
A brief description and discussion of the
Weibull distribution function is presented. It
Includes a method for determining
the
Weibull parameters, and the use of these
parameters in identifying unknown samples
as belonging to more well-known
distribution functions such as the normal, exponential and Chi Square.
A method for comparing two samples
using an integration ofthe sum of the alpha
and beta errors is also presented.
Finally there is offered an explanation as to
why the use of the Weibull
distribution
should be more sensiUve in determining
differences between small samples of data
than more conventional methods of hypothesis testing.

* Department of Neurosurgery and Neurology,
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•'Department of Internal Medicine, Rheumatic
Disease Section, Baylor College of Medicine,
Houston, Texas, 77025
*** Division of Rheumatology, Henry Ford
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Address reprint requests to Dr. McCrum at Henry
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Methods
A. Clinical
Twenty-seven patients meeting the ARA
criteria for classical rheumatoid arthritis, and
with the disease of less than 5 years' duration, were randomized to either a control or
treated group. There were 14 patients in the
control group and 13 in the treated group.
The similarity of disease severity and duration in the two groups was established prev i o u s l y . ' G o l d salts or placebo were
administered for at least two years. The
patients were examined at specified times
regularly throughout the study."* The details
o f t h e c l i n i c a l measurements evaluated
herein were published previously.'

I N 1951 Waloddi Weibull described a simple distribution function with the only condit i o n s t h a t it be n o n - z e r o a n d n o n decreasing.^ He said the function had wide
applicability and presented seven examples
ofthe useofthisfunction in statistics. Most of
the examples were in biostatistics. In one
example (the fatigue life of steel) the independent variable was time; subsequently
this use of the function as a failure rate
distribution has been found most useful in
reliability testing. It isalso finding increasing
acceptance in engineering and physics for
use in other than life testing procedures.
Johnson and Leone^ refer to "Weibullizing"
a variety of distribution functions such as the
normal, exponential, beta, gamma and Chi
Square. However, its use has been almost
totally neglected in the field of biostatistics,
as described in his remaining examples. The
purpose of this paper is to show that this
function is useful in evaluating clinical data
and has theoretical advantages over the
classical statistical hypothesis-testing techniques which assume a normal distribution.
To illustrate these points the Weibull distribution is compared with analysis of variance in evaluating a double blind trial of
gold therapy in rheumatoid arthritis.

This paper compares the initial pre-treatment examinations and the examinations at
6, 12 and 24 months. The differences between pre-treatment and subsequent measurements of grip strength, ring size, joints
showing synovitis, walking time and lace
tying time were analyzed. The serum proteins were determined at the beginning and
at the end ofthe study.
B. Stadstical
Since our samples are drawn from unknown populations, the population parameters must be estimated from the samples.
This is true of any statistical procedure when
the population parameters are unknown.
The Weibull distribution uses three parameters to identify the population. These are
the: origin (alpha), the shape (beta) and the
scale (theta). Thus the cumulative Weibull
distribution function:

Gold salts have been used to treat rheumatoid arthritis for many years. However,
there are few studies on the effectiveness of
this treatment. Recently Sigler etaP reported
that some features of the disease were improved by treatment with gold salts, using
analysis of variance for data evaluation. It
was recognized that the use of "classical"
statistics such as analysis of variance or
Student's " t " test was perhaps inappropriate
for evaluating small samples of 13 and 14
data points. For this reason the data were reevaluated using the Weibull distribution
function. To our knowledge this is the first
application forthe Weibull distribution function to a therapeutic trial.

F(x) = 1and the density function;
•1
f(X) = / 3 ( X - a )

• V e-a )

It is evident that F (x) is a log log function.
When the relationship between the log-
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arithmic values of the sample x and the log
log values of F (x) is linear, the sample is said
to have come from a population having a
Weibull distribution. Thus the slope of the
best fit line through the sampledata points is
the best estimate of the shape parameter
beta. The intercept of this line with the
abscissa yields the origin (parameter alpha).
When X = theta the Weibull function reduces to

F(x) = 1 - e

compared between the two groups. Since
there were 14 control and 13 treated patients,
data points were 28 and 26 forthe respective
groups.
When these data points were entered into
the computer (see Appendix 1) the following
values were derived: alpha (the origin) of the
control group was zero; beta (shape) was
1,28 (a nearly exponential distribution); and
theta (scale) was equal to 17.69. The median
was 6.5 ounces. Alpha was 5, beta was 1.2,
and theta was 39.06 for the treated group.
The median was 18.72 ounces.

0.632.

For this study a computer was used to determine the best fit line through the data using
successive estimates of alpha as a starting
point. Appendix 1 describes the format ofthe
computer program used in determining the
parameters of samples of grip strength in the
control and treated groups.

The confidence " c " that the treated group
had the greater grip strength after six months
was 0.9964 (Appendix II). The analysis of
variance of these two samples yielded an
alpha-error of 0.035 (significant at the 0.05
level).
The data for grip strength differences at 12
and 24 months were evaluated in the same
fashion. All samples showed nearly exponential distributions with zero origin. At 12
months the confidence that the treated group
was better was 0.9428, and at 24 months was
0.9885. Comparison ofthe Weibull distribution analysis with the analysis of variance is
shown in Table 1. Using analysis of variance,

Having established the Weibull parameters for our two samples to be compared,
we then establish the probability of a difference between them as a confidence " c " .
This in essence represents the minimum
integral or overlap of the Type 1 (alpha) and
Type 11 (beta) errors of classical hypothesis
testing. The use of alpha and beta in this
instance should not be confused w i t h
Weibull parameters having the same name.
The rationale for the confidence " c " is explained by L. G. Johnson." Since that publ i c a t i o n has a l i m i t e d c i r c u l a t i o n , the
introduction to the article is reproduced in
Appendix III.

TABLE I
(Grip Stirength)

ANOVA

^6 = ^6

WEIBULL

H,

ANOVA

H :

WEIBULL

H,

Results
Cnp strength analysis
Grip strength was measured in ounces of
water per square inch for each hand in all
patients in this study. Initial measurements,
made before treatment, revealed no difference between the patients selected as
controls and those to be treated. Differences
in strength between the initial measurements
and measurements after six months were

ANOVA

WEIBtILL
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^6 > S
= ^12

= 0.9964

a = 0.008
C = 0.9428

^24 " ^^24

H,

a = 0.035

T

24

>C
24

a = 0.025
C = 0.9885
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TABLE I I

the null hypothesis Ho is accepted if the a
error is > 0.05. Using the confidence method the Hypothesis H, is accepted if " c " is
> 0.90. In this instance there was no conflict
between analysis of variance and the confidence method. Ho was rejected by the former and H| accepted by the latter.

CRing Size)

ANOVA

The choice of a 0.90 confidence level is
purely arbitrary in this instance. It is the usual
level of confidence accepted in physics and
reliability engineering, and was considered
in this case an acceptable level for the
purpose of the study. It must be remembered
that we are considering the probability of a
difference between two samples whereas in
using analysis of variance the level of the
alpha error is not necessarily indicative of a
difference between two samples. In point of
fact, selection of too small an alpha error
(0.01 for instance) may mask the correct
probability of a difference by creating too
large a beta error. This point is enlarged
upon later.

H :
o
WEIBULL H,

C =T
6
6

a = 0.05

^6 < S

C = 0.9999

ANOVA

C12, =
T
<
12

H :

WEIBULL H

ANOVA
WEIBULL

H

T
"12
C
12

S 4 = ^24
1

:

T , . < C.,^
24
24

— a = 0.005
— C = 0.9999

— a = 0.23
—

= 0.9032

were zero and the shape parameter ranged
from 1.0 to 1.4, indicating the distribution
form was nearly exponential.
Forthe 6-month period, the confidence of
a difference between the treated and control
group was 0.55 which is near pure chance.
At 12 and 24 months, however, the confidence that the treated group showed fewer
joints with synovitis was 0.9999 for both
periods. It will be noted (Table 111) that at

Ring size analysis
The differences in ringsizes at6,12 and 24
months were evaluated bythe same method.
The Weibull parameter alpha was zero for all
samples. The parameter beta ranged from
1.4 to 1.8. These values indicate that all the
samples were highly skewed to the left ofthe
mean but were not exponential. Confidence
levels that the ring size differences for the
treated group were smaller than those for the
control group were 0.9999 (certainty) for the
6- and 12-month periods and 0.9032 for 24
months.

TABLE I I I
(Sum of J o i n t s Showing Synovitis)

ANOVA

Analysis of variance yielded alpha-errors
sufficiently small that the null hypothesis
would be rejected for the 6- and 12-month
periods. The data from the 24-month period,
however, yielded a large alpha-error. (See
Table II).

H :
o

= T,
6

a = 0.10

WEIBULL H-^: Tg < Cg

C = 0.55

ANOVA

H :
0
WEIBULL H, :
1

Sum of joints analysis
Analysis ofthe difference in the number of
joints showing synovitis 6,12 and 24 months
revealed origins ofthe Weibull distributions

ANOVA
WEIBULL
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6

C,_ = T - .
12
12
T
<C
12
12

H^: C^^ = T24
1

:

T..,, < C
24
'24

— a = 0.015
— C = 0.9999

a = 0.09
C = 0.9999
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TABI£ I V

both the 6-month and 24-month evaluations, the alpha-error was essentially the
same, whereas the c o n f i d e n c e level
changed from 0.55 to 0.9999. This points
out the importance of considering the betaerror as well as the alpha-error in determining differences between samples. This becomes especially important when dealing
with highly skewed distributions as in this
case.

CWalk±ng Time)

6 inontils
H :
o

Walking dme analysis
Initially the treated and control groups
showed no difference in thetime required to
walk a measured distance. Differences in
walkingtime were calculated at6,12 and 24
months. Both treated and control patients
showed a decrease in walkingtime over the
entire length of the study. At 6 months the
decrease in time was similarfor both groups.
At 12 and 24 months, however, the treated
group showed a greater decrease than the
control group with the high probability, " c "
= 0.9999 for both 12 and 24 months, that
these changes were valid. These samples
were also nearly exponentially distributed.
Analysis of variance failed to indicate any
differences between the treated and controls, (see Table IV).

C

T

a = 0.75

T < C

C = 0.58

«o =

C = T

a = 0.75

H :
1

T < C

C = 0.9999

C = T

a = 0.75

T < C

C = 0.9999

12 mont±is

24 ittoiths
H :
o

include lace tying time, hemoglobin, and
white blood cell count.

Serum proteins analysis
Serum protein electrophoresis was performed on samples from each subject at the
beginning and end ofthe study. There were
no differences between the treated and control groups in either total protein, albumin or
globulin at the beginning. At the end of the
study there was no change in total protein
but albumin values were lower (c = 0.956)
and globulin levels higher (c = 0.981) in the
control group than in the treated group.
Analysis of variance showed only the albumin level to be lower in the control group
at the end o f t h e study (see Table V).

Discussion
The Weibull distribution function is a very
convenient and flexible probability distribution. Itrequiresofthe sample data only that it
be non-zero and non-decreasing in its
cumulative sum. It is widely used in industry
because empirically it has been proven reliable in evaluating small samples of test data.
Almost all medical data sets fit these conditions. Yet use ofthe Weibull distribution for
evaluatingclinical data has had such limited
application that it is essentially a new approach. Its use, therefore, deserves careful
consideration.

Tests showing the treatment effect
Several other measurements were evaluated which showed no differences between
the treated and control groups by either the
ANOVA or Weibull methods. These tests

Perhaps its strongest attribute for its usefulness is its ability to replace a number of
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TABLE V

essentially a normal distribution. A value
lessthan 3.5 indicates skewingof the data to
the left of the mean and a value greater than
3.5 shows skewing to the right of the mean.

(Serum Proteins)

If the parameters ofthe parent population
are unknown, then for any statistical inference the sample must be assumed to be a
random sampleofthat population. Since this
must be the case, the parameters of the
sample are the best estimators ofthe parameters of the parent population. Thus, for
example, if the sample is exponentially distributed, it must be assumed that the parent
population is also exponentially distributed.
In such case the parameters of mean and
variance will have little or no usefulness in
establishing a meaningful inference. O n the
other hand, if it is arbitrarily assumed that the
parent population is normally distributed
then it is obvious that the exponentially
distributed sample is nota random sample of
that population. A statistical inference in
such case would not be valid. If the Weibull
parameters of the sample are established
first, errors concerning population character
will not be made. This is in contrast to using
analysis of variance. In using analysis of
variance, as in the present study, the mean
and variance of the population were estimated from the sample. This required two
arbitrary assumptions: 1)the parent population was normally distributed, and 2) the
sample was a truly random representation of
this normal population as defined mathematically (5) by the relationship:

Total Protein
H :

o

=
I
^1

<

cI — a
^1

= 0.35

C = 0.7332

H :
o

=

a = 0.75

"1 =

< Cp

C = 0.8039

Albumin
H : C = T
1
o
I
H : C, < T
1
I
Ho = CF = Tp
Cp < TF

a - 0.26
C = 0.8044
a = 0.028
C = 0.9562

Globulin
H : Cl = T j
o
% = Cl < T l
H :

o

a = 0.08
C = 0.914

S =TF

a = 0.005

Cp < Tp

C = 0.9811

P{XK

better-known functions such as the normal,
exponential, Chi Square, gamma and beta
distributions. When the shape parameter
beta equals one the distribution becomes
exponential.

F(x)

• Xk —

Fk ( x „

In point of fact, neither of these assumptions
was supported by the data available from
this study. As can be seen from the results
most of the samples were either exponentially distributed or highly skewed to the left
of the mean. It may be argued that small
samplesdrawn from normal populations are
skewed and corrections can be made forthe
skewness. This argument is valid only when
the population distribution is known with
certainty.

1-e

Further, it has been determined empirically
that when the shape parameter equals 3.5
the mean and median coincide and we have
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The distribution functions of biological
data are generally not known, and, furthermore, should not be assumed to have a
normal distribution. This is particularly true
if the data are oriented in the time domain.
Clinical studies often are concerned with a
" l i f e " process, either that of the patient or of
a disease. Such " l i f e " processes differ in
their distribution functions. Some are characterized by "infant mortality", some by
"random decay" and others by "old age
survival". This being the case, such studies
should be evaluated by an appropriate "life
testing" distribution such as the exponential,
log normal, gamma, etc. The Weibull distribution proves most useful in this regard
because it characterizes most of these. As
mentioned before, Weibull parameters adequately describe numerous d i s t r i b u t i o n
functions i n c l u d i n g the normal and C h i
Square.

those reached by analysis of variance. In
some instances, however, analysis of variance failed to detect small differences between the treated and control groups that
were held to be significantly different when
evaluated by the Weibull method. The basis
for such discrepancies has already been
discussed. In the present study in particular
two factors stand out.
In the first instance analysis of variance
depends upon the mean and variance for
information. Since most data samples in this
study were nearly exponential in distribution, their mean and variance carried little
meaningful information.
In the second instance the consideration
of only alph-errors ratherthan consideration
of both alpha and beta errors together is
emphasized. In classical statistics, an inference is accomplished by hypothesis testing. An hypothesis is made, and from the
sample data a probability of an error is
established if the hypothesis is accepted.
This probability is called the alpha-error. A
probability that an error will be made if the
hypothesis is rejected is also present. This
probability is Called the beta-error. The two
probabilities are mutually exclusive; both
the alpha-error and the beta-error contribute
to the total probability of an error in either
accepting or rejecting the hypothesis. The
correct level of probability that should be
chosen for rejecting or accepting an hypothesis then is that level which minimizes the
sum of the alpha and beta errors (see Appendix 111). In actual practice this is rarely done.
An alpha-error (usually very small) is arbitrarily chosen, and the hypothesis is accepted or rejected, depending on the alphaerror calculated from the samples.

Another advantage ofthe Weibull method
is that populations can be compared at
different percentiles other than the mean.
Thus two different groups can be compared
at10% level, 90% level orthe 50% level (the
median). Analysis of variance and Student's
" t " test compare only the means, which
usually vary from the 40th percentile to the
60th percentile, depending on the amount
and direction ofthe skewness ofthe population. Thus, for example, some treatment
might make 10% of the population worse,
improve another 10%, but "on the average"
show no effect. This could be revealed by
Weibull analysis at varying percentiles.
The shape parameter beta may also be
compared fordifferent Weibull distributions.
It may happen that two populations will
"average out" equally but the character of
their distributions may be quite different.
These differences can be determined and
q u a n t i f i e d by e v a l u a t i n g t h e s h a p e
parameter.

The W e i b u l l analysis uses a different
method of making a statistical inference. A
"confidence" is established which is a measure of the overlap between two adjacent
probability density functions. It is then in
essence an integration of the alpha and beta
errors, (Figure 1).

In the study reported here, most of the
conclusions based on evaluation by the
Weibull analysis were in agreement with
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CONTROL

TREATED
/

DISTRIBUTION OF MEANS
\

. Computed
\ alpha error

r
/
beta 11 IMTK.

\

error^fl

1^^= II lllillilNIIINHTTr*^ 1
\

01=0.23

/

ANOVA method accepts
the NULL HYPOTHESIS

WEIBULL method
rejects the
NULL HYPOTHESIS

Figure 1
Hypothesis testing of ring size difference at 24 months. Comparison of hypothesis testing using a
predetermined alpha error, as in ANOVA, with the confidence level determined by integrating the overlap
of the alpha and beta errors.

the method appears to be sensitive in detecting small differences in small samples. A
major advantage in using the Weibull distribution for clinical data analysis is that one
does not have to assume the population has
a particular shape such as bell-shaped curve

Conclusion
We believe that the application of Weibull
distribution analysis to clinical data, as illustrated in the gold trial reported here, is valid
and will yield reliable results. In addition.

180

Analysis of clinical data
o f the n o r m a l d i s t r i b u t i o n or the d e c a y i n g
s l o p e o f an e x p o n e n t i a l d i s t r i b u t i o n .

A c k n o w led g e m e n t s

The

shape is d e t e r m i n e d f r o m the s a m p l e , m u c h

T h e a u t h o r s w i s h t o t h a n k t h e J. M .

as the shape o f t h e C h i Square d i s t r i b u t i o n is

Richards' Laboratory, Grosse Pointe

d e t e r m i n e d by the s a m p l e . W e b e l i e v e that

M i c h i g a n , for its c o n t r i b u t i o n o f c o m p u t e r

W e i b u l l d i s t r i b u t i o n analysis deserves w i d e r

t i m e a n d p r o g r a m s in c o m p l e t i n g this p r o -

trial in c l i n i c a l p r o b l e m s since o n l y e x p e r i -

j e c t ; and the M i c h i g a n Chapter,

e n c e f r o m m o r e e x t e n s i v e use w i l l establish

F o u n d a t i o n , for the

its true v a l u e .

c l i n i c a l study.

Park,

Arthritis

grant to s u p p o r t

the
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APPENDIX I

Step
Step
Step
Step
Step
Step
Step
Step
Step
Step
Step

Computer Program Format for Weibull
Parameters of Grip Strength of Treated Patients
Input
Step 1.
Step 2.

Estimates of origin (alpha): 0, 5, 10.
Data (not ordered): x,, x^,
X24.

Output
Step 1.

Data (ordered listing): Xj,,

7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.

Median = 18.8633.
Origin (alpha) = 5 (from inpuO.
Shape (beta) = 1.1231.
Scale (theta) = 39.0681.
Goodness of fit = 0.9705.
Median = 18.72.
Origin (alpha) = 10 (from input).
Shape (beta) = 10.0581.
Scale (theta) = 29.2672.
Goodness of fit = 0.9371.
Median = 18.8111.

Xj2, . . . . Xj24.

Step 2.
Step 3.
Step 4.
Steps.
Step 6.

Comment

Median ranks of: Xj,, Xj2,
Xj24.
Origin (alpha) = 0 (from input).
Shape (beta) = 1.0280.
Scale (theta) = 43.6483.
Goodness of fit = 0.9500.

1= Distribution of
PARAMETER |

The best goodness of fit test equals 0.9705 (Step
11). Therefore the best estimates of the Weibull
parameters are: alpha = 5 (Step 8), beta = 1.1231
(Step 9) and theta = 39.0618 (Step 10).

OVERLAP
AREA
OR
INTERFERENCE
AREA

Distribution of
PARAIVIETER2

X=Value of Parameter-^
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APPENDIX II

The question which now can be asked is " H o w
are these two statistical techniques related (i.e.,
sample comparison and hypothesis testing)?"
More specifically, we can ask " W h a t is the relationship between a, j i , and C?"

Computer Program Format for "Confidence" of
a Difference in Grip Strength Between Treated
and Control Groups.
Input
Step 1.

Step 2.

Step 3.
Step 4.

Acomparison of two samples is generally done
by comparing a particular type of population
parameter or quantile level in the two samples.
The parameter chosen could be the mean in the
case of normal distribution, or characteristic values n the case of Weibull
distributions.

Control group values: alpha = 0,
beta = 1.276, theta = 17.69, sample
size = 28.
Treated group values: alpha = 5,
beta = 1.1231, theta = 39.06,
sample size = 24.
Percentile compared = 0.5 (median).
Null ratio = 1 (at least different).

The corresponding hypothesis which istested is
then the one which states that the mean of an
observed sample belongs in population^ with
meani, or that the characteristic value 9 of an
observed sample belongs in population^ with
characteristic valuex = Si (^^ and
being the
characteristic values o f t h e two possible populations from which the sample could come).

Output
Step 1.
Step 2.
Step 3.
Step 4.
Step 5.

Estimated mean of control
population = 14.329.
Estimated standard deviation of
control population = 2.836.
Estimated mean of treated
population = 31.97.
Estimated standard deviation of
treated population = 6.43.
Confidence = 0.9964.

In order to make a comparison of parameters vs
parameteri we need distribution functions for both
parameters {say, the estimated mean of populations) and parameters (the estimated mean of
popu/a!/on2).
Once these distribution functions are known we
construct an interference diagram, as in Figure 1.

Comment
Given the Weibull parameters for two samples,
the program compares the two samples at any
percentile level and at any selected magnitude of
difference. In this example the medians were
compared and found to be at least different with a
confidence 0.9964. If we had selected a null ratio
of 2, then the program would have computed the
confidence that the median of one sample was at
least twice as large as the median of the other
sample.

Bulletin No. 2, Page 2
From Figure I it is possible to calculate the
probability that a random element from II exceeds
a random element from I. Thisisthen
definedtobe
the confidence that parameters > parameters.
Let the PDF (Probability Density Function) of I
be fl (X).
Let fl (X) = PDF of II.
Let Fl (X) = CDF (Cumulative Distribution
Function) of I.

APPENDIX III
From Statistical Bulletin: Reliability & Variation
Research. Leonard G. Johnson, Editor, Vol. 2,
Bulletin 2, M a y 1972, Page 1.
Sample comparison

vs hypothesis

Let F2 (X) = CDF of II.
Then

testing

C = j V i (X) f2 (X) dX

In comparing two samples we calculate the
confidence C that one ofthe samples represents a
population which is superior to the population
represented by the other sample.

According to formula 1 the confidence C increases as in the overlap area between fi (X) and
f2 (X) is made smaller, until when there is no
overlap, the confidence becomes 1 (i.e., 100%
or certainty) that whatever is selected in II will
surely exceed whatever is selected in I. O n the
other hand, i f f i (X) and f2 (X) are identical (100%
overlap), it follows that there is a 50-50 chance
(i.e., 50% confidence orC-.5) thatthe selection
from II will exceed the selection from I.

In testing the hypothesis that a given sample
belongs to a population superiorto some standard
population we specify so-called a and /3 errors,
and determine whether under the {a, /3) pair
chosen we should acceptor reject the hypothesis
that the sample belongs to the standard
population.
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